Black Rock Inc. Allovir, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Allovir, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,385,831 shares of ALVR stock, worth $2.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,385,831

Previous 3,526,112 3.98%

Holding current value

$2.57 Million

Previous $2.4 Million 7.34%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.64 - $0.78 $89,779 - $109,419	-140,281 Reduced 3.98%	3,385,831 $2.57 Million
Q4 2023 Feb 13, 2024	SELL	$0.68 - $2.39 $217,269 - $763,638	-319,514 Reduced 8.31%	3,526,112 $2.4 Million
Q3 2023 Nov 13, 2023	BUY	$2.15 - $3.64 $1.12 Million - $1.9 Million	521,274 Added 15.68%	3,845,626 $8.27 Million
Q2 2023 Aug 11, 2023	BUY	$3.17 - $5.82 $2.06 Million - $3.79 Million	650,871 Added 24.35%	3,324,352 $11.3 Million
Q1 2023 May 12, 2023	SELL	$3.94 - $7.05 $564,609 - $1.01 Million	-143,302 Reduced 5.09%	2,673,481 $10.5 Million

Q4 2022 Feb 13, 2023	BUY	$4.7 - $9.98 $701,724 - $1.49 Million	149,303 Added 5.6%	2,816,783 $14.5 Million
Q3 2022 Nov 14, 2022	BUY	$4.13 - $8.79 $780,053 - $1.66 Million	188,875 Added 7.62%	2,667,480 $21 Million
Q2 2022 Aug 12, 2022	BUY	$3.26 - $7.06 $807,456 - $1.75 Million	247,686 Added 11.1%	2,478,605 $9.67 Million
Q1 2022 May 12, 2022	BUY	$6.75 - $13.52 $423,542 - $848,339	62,747 Added 2.89%	2,230,919 $15.1 Million
Q4 2021 Feb 10, 2022	BUY	$12.94 - $25.99 $4.59 Million - $9.23 Million	354,993 Added 19.58%	2,168,172 $28.1 Million
Q3 2021 Nov 09, 2021	BUY	$16.97 - $25.06 $1.11 Million - $1.65 Million	65,695 Added 3.76%	1,813,179 $45.4 Million
Q2 2021 Aug 11, 2021	BUY	$19.44 - $25.06 $34 Million - $43.8 Million	1,747,484 New	1,747,484 $34.5 Million

Others Institutions Holding ALVR

# of Institutions

Shares Held

49.1M

Call Options Held

385K

Put Options Held

2.3K

View Full List

About Allovir, Inc.

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $70.7M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

More about ALVR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account